Isomorphic Labs, spun off from Google DeepMind, is in talks to raise about $5 billion, Bloomberg reports. According to the results of the round, the key of artificial intelligence to search for new drugs is expected to be valued at about 50 billion dollars. The startup raised $2.1 billion in May and planned to start the first clinical trials by the end of 2026.